Search

Author/Creator Micaleff, Alain

1. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies†. (13th May 2014)

Authors:
Mt‐Isa, Shahrul; Hallgreen, Christine E.; Wang, Nan; Callréus, Torbjörn; Genov, Georgy; Hirsch, Ian; Hobbiger, Stephen F.; Hockley, Kimberley S.; Luciani, Davide; Phillips, Lawrence D.; Quartey, George; Sarac, Sinan B.; Stoeckert, Isabelle; Tzoulaki, Ioanna; Micaleff, Alain; Ashby, Deborah; On be...
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 23:Number 7(2014:Jul.)
Page Start:
667
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology†. (5th July 2014)

Authors:
Hallgreen, Christine E.; van den Ham, Hendrika A.; Mt‐Isa, Shahrul; Ashworth, Simon; Hermann, Richard; Hobbiger, Steve; Luciani, Davide; Micaleff, Alain; Thomson, Andrew; Wang, Nan; van Staa, Tjeerd P.; Downey, Gerald; Hirsch, Ian; Hockley, Kimberley; Juhaeri, Juhaeri; Metcalf, Marilyn; Mwangi, J...
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 23:Number 9(2014:Sep.)
Page Start:
974
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Literature review of visual representation of the results of benefit–risk assessments of medicinal products. Issue 3 (2nd November 2015)

Authors:
Hallgreen, Christine E.; Mt‐Isa, Shahrul; Lieftucht, Alfons; Phillips, Lawrence D.; Hughes, Diana; Talbot, Susan; Asiimwe, Alex; Downey, Gerald; Genov, Georgy; Hermann, Richard; Noel, Rebecca; Peters, Ruth; Micaleff, Alain; Tzoulaki, Ioanna; Ashby, Deborah
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 25:Issue 3(2016)
Page Start:
238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Literature review of visual representation of the results of benefit–risk assessments of medicinal products†. Issue 3 (2nd November 2015)

Authors:
Hallgreen, Christine E.; Mt‐Isa, Shahrul; Lieftucht, Alfons; Phillips, Lawrence D.; Hughes, Diana; Talbot, Susan; Asiimwe, Alex; Downey, Gerald; Genov, Georgy; Hermann, Richard; Noel, Rebecca; Peters, Ruth; Micaleff, Alain; Tzoulaki, Ioanna; Ashby, Deborah
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 25:Issue 3(2016)
Page Start:
238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study. (September 2016)

Authors:
Goetghebeur, Mireille M.; Wagner, Monika; Nikodem, Mateusz; Zyla, Agnieszka; Micaleff, Alain; Amzal, Billy
Journal:
Therapeutic innovation & regulatory science
Issue:
Volume 50:Number 5(2016:Sep.)
Page Start:
620
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Recommendations for benefit–risk assessment methodologies and visual representations§. Issue 3 (22nd January 2016)

Authors:
Hughes, Diana; Waddingham, Ed; Mt‐Isa, Shahrul; Goginsky, Alesia; Chan, Edmond; Downey, Gerald F.; Hallgreen, Christine E.; Hockley, Kimberley S.; Juhaeri, Juhaeri; Lieftucht, Alfons; Metcalf, Marilyn A.; Noel, Rebecca A.; Phillips, Lawrence D.; Ashby, Deborah; Micaleff, Alain
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 25:Issue 3(2016)
Page Start:
251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗